Ohio Advises Temporary Pause for Johnson & Johnson COVID-19 Vaccine

Today, Governor Mike DeWine, Ohio Department of Health Director Stephanie McCloud, and Ohio Department of Health Chief Medical Officer Bruce Vanderhoff, MD, are advising all Ohio vaccine providers to temporarily pause using the Johnson and Johnson (Janssen) vaccine. 

This is in response to a statement by the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) recommending a pause in the use of the Johnson and Johnson vaccine following extremely rare blood-clotting events of six people in the U.S. after receiving the vaccine.

Later today the FDA and the CDC will hold a media briefing. Tomorrow, the CDC will convene a meeting of the Advisory Committee on Immunization Practices to further review these cases.

Officials with the Ohio Department of Health are following this situation closely and we will share their updates as necessary.

View this email in your browser
You are receiving this email because of your relationship with State Medical Board of Ohio. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from contact@med.ohio.gov to contact@med.ohio.gov
30 East Broad Street, 3rd Floor, Columbus, Ohio, 43215

Update Profile/Email Address | Forward Email | Report Abuse